← Back to Search

Screening Tool for Substance Abuse (TAPS-ESP Trial)

N/A
Waitlist Available
Led By Katherine Sanchez, PhD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at a new screening and assessment tool for substance use in primary care settings.

Who is the study for?
This trial is for Spanish-speaking adults who are current patients at the clinic and can read Spanish. It's designed for those seeking screening and treatment for substance use, including tobacco, alcohol, prescription drugs, or other illicit substances.
What is being tested?
The study aims to validate the TAPS-ESP as a tool in primary care settings for identifying and assessing substance use issues. Participants will self-administer this screening tool on an iPad.
What are the potential side effects?
Since this trial involves only a screening process using an electronic platform (TAPS-ESP), there are no direct medical side effects associated with participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ethanol
Secondary study objectives
Alcohol Use Disorders Identification Test (AUDIT) for concurrent and convergent validity of the TAPS
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) for concurrent and convergent validity of the TAPS Tool
CAGE (Cut Down, Annoyed, Guilty, Eye-Opener) for concurrent and convergent validity of the TAPS
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Self-Administration followed by Interviewer-AdministeredActive Control1 Intervention
Screening and validation of assessment tool translated into Spanish
Group II: Interviewer-Administered followed by Self-AdministrationActive Control1 Intervention
Screening and validation of assessment tool translated into Spanish

Find a Location

Who is running the clinical trial?

COG AnalyticsOTHER
3 Previous Clinical Trials
230 Total Patients Enrolled
Baylor Research InstituteLead Sponsor
206 Previous Clinical Trials
202,425 Total Patients Enrolled
Katherine Sanchez, PhDPrincipal InvestigatorBaylor Scott and White Research Institute
3 Previous Clinical Trials
600 Total Patients Enrolled

Media Library

TAPS-ESP Clinical Trial Eligibility Overview. Trial Name: NCT05476588 — N/A
Tobacco Use Research Study Groups: Self-Administration followed by Interviewer-Administered, Interviewer-Administered followed by Self-Administration
Tobacco Use Clinical Trial 2023: TAPS-ESP Highlights & Side Effects. Trial Name: NCT05476588 — N/A
TAPS-ESP 2023 Treatment Timeline for Medical Study. Trial Name: NCT05476588 — N/A
~121 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top